Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

Let’s take our IPIX hats off for a moment and

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72445
(Total Views: 475)
Posted On: 04/17/2019 11:03:34 AM
Posted By: Mo

Let’s take our IPIX hats off for a moment and put on our Big Pharma M&A hat. If you were the CEO of Big Pharma X (BPX) and one of your Business Development/M&A guys comes in the board room with the following proposal what would you do? “We have an opportunity in the OM market to capture $600M to $1.2B annually with great growth potential with a Phase 3 ready Preventative drug called Brilacidin. After royalties BPX would attain 85% of the above revenue after paying only 15% in Royalty payments. This would add annual net revenue of $510M to $960M in the first year for that single indication. This drug also fits in perfectly with our objective to grow our presence in our Oncology Division. We can lock up exclusive rights for this drug on this specific indication for only $100M in upfront cash. There are also other multi-billion dollar indications that this drug addresses including the IBD, ABSSI and dermatitis markets using this same antibiotic with anti-inflammation benefits. I believe for an additional $100M upfront we could lock up this Franchise drug for ALL indications and have world-wide exclusive rights that will produce a multi-billion dollar revenue stream annually for a one time investment of only $200M in development capital. The company that owns the rights to this product IPIX want additional milestone payments as indications successfully pass phase 3 studies but those payments would be risk free to us at that point in time. Our technical team believes there is an 90% + chance of a successful phase 3 B-OM if we assign a couple of our top Clinical and Project Managers on this phase 3 study.“

If I was the CEO I would clarify this proposal and evaluate it from a net/net perspective like all good CEO’s do. “So for a $200M upfront investment we can secure worldwide rights and add a franchise drug to our portfolio that brings in at least a half billion dollars in net revenue year 1 and possibly upwards of $3B annually by year 3 or 4 with multiple indications? Make sure you lock this deal down before our competitors get us into a bidding war. Nice work Captain Obvious.”


(11)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us